majority of patients treated for post-radical retropubic prostatectomy (RRP) ED are treated with phosphodiesterase (PDE)-5 inhibitors; this critique targets this course of oral agencies. guys are as potent postoperatively as they were preoperatively and the term potent is progressively defined in terms of response to PDE-5 inhibitors.5 In a nonrandomized open-label mixed-dose nonconsecutive study of… Continue reading majority of patients treated for post-radical retropubic prostatectomy (RRP) ED are